Testing myWHI: Online Self-help Programs for Headaches
Comparative Effectiveness of Two Self-guided Web-based Interventions for Youth and Young Adults With Migraine
1 other identifier
interventional
424
1 country
1
Brief Summary
This randomized controlled trial will compare the effectiveness of two online self-guided programs for youth and young adults with migraine against usual care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 5, 2018
CompletedFirst Posted
Study publicly available on registry
April 20, 2018
CompletedStudy Start
First participant enrolled
May 4, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2020
CompletedOctober 16, 2018
October 1, 2018
1.4 years
April 5, 2018
October 15, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Clinically significant improvement (50% reduction or greater) in number of headache days in a 4-week period from baseline to 4-months post-randomization
An electronic headache diary will be asked to be used for 4 weeks. Each day participants will be asked to record whether or not they have experienced a headache.
At baseline and at 4-months post-randomization
Secondary Outcomes (5)
Statistically significant improvement in peak headache severity in a 4-week period from baseline to 4-months post-randomization
At baseline and at 4-months post-randomization
Statistically significant improvement in headache-related functional impairment from baseline to 4-months post-randomization
At baseline and at 4-months post-randomization
Statistically significant improvement in depressive symptomatology from baseline to 4-months post-randomization.
At baseline and at 4-months post-randomization
Level of acceptability to the treatments (i.e., PRISM and SPHERE)
At 4-months post-randomization
Level of acceptability to the treatments (i.e., PRISM and SPHERE)
At 4-months post-randomization
Study Arms (3)
SPHERE
EXPERIMENTALIt is an online self-guided comprehensive cognitive-behavioural therapy program that offers a headache diary, learning modules that teach a variety of cognitive and behavioural skills to cope better with their headaches, and a discussion forum where users may interact.
PRISM
EXPERIMENTALIt is an online self-guided brief cognitive-behavioural therapy program that offers a headache diary and helps users discover their headache triggers and non-triggers. Then the program provides the users with a few personalized recommendations to help them to cope with their triggers.
Usual care
NO INTERVENTIONInterventions
Eligibility Criteria
You may qualify if:
- aged 14-40 years
- fluent in the English language (i.e., speaking, reading and writing);
- for 14-17 year olds: suffer from headaches for a minimum of three months
- for 18-40 year olds: suffer from headaches for a minimum of one year
- suffer from migraine headaches as indicated with a score of 2 and above on the ID Migraine
- have a Smartphone as PRISM has been designed to be accessed from a Smartphone and SPHERE encompasses the myWHI diary which has also been designed to be used from a Smartphone
- use the Smartphone for activities other than texting and calling (e.g., email, Facebook) as the programs are designed for migraineurs who are familiar with using Smartphones and use them in their daily life
- have daily Internet access from their Smartphone, because running the programs require an Internet connection
- minimum of four headache days during 4 weeks that they are asked to use an electronic headache diary
You may not qualify if:
- health care professional has not ruled out any underlying medical condition related to their headaches (e.g., head trauma, meningitis)
- are pregnant, planning to get pregnant (in the next 4 to 6 months), or breastfeeding, as hormonal changes are known to exert potent influences on migraine headaches
- have an impairment which compromises their ability to give informed consent
- having been diagnosed with psychosis and/or schizophrenia, because a past or current diagnosis may likely interfere with the participants ability to fully participate in the study
- have participated in our recent three-armed pilot RCT (i.e., any participant who consented and was randomized)
- they complete less than 50% of daily entries (i.e., less than 14 daily entries) in an electronic headache dairy when they asked to use it for 4 weeks
- More than 15 headache days during the 4 weeks that they are asked to use an electronic headache diary
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- IWK Health Centrelead
- Nova Scotia Health Research Foundationcollaborator
- Canadian Institutes of Health Research (CIHR)collaborator
Study Sites (1)
IWK Health Centre
Halifax, Nova Scotia, B3K 6R8, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anna Huguet, PhD
IWK Health Centre
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
April 5, 2018
First Posted
April 20, 2018
Study Start
May 4, 2018
Primary Completion
October 1, 2019
Study Completion
May 1, 2020
Last Updated
October 16, 2018
Record last verified: 2018-10
Data Sharing
- IPD Sharing
- Will not share